| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 41 |
| 1 | RUXOLITINIB | 37 |
| 2 | UPADACITINIB | 34 |
| 3 | VENETOCLAX | 26 |
| 4 | ASPIRIN | 25 |
| 5 | ASPIRIN 325 MG | 25 |
| 6 | ASPIRIN 81 MG | 25 |
| 7 | METHOTREXATE | 24 |
| 8 | METHOTREXATE SODIUM | 24 |
| 9 | LEFLUNOMIDE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTAZOLAM | 12 | 0.0061 |
| 1 | CEFTAZIDIME, AVIBACTAM | 1 | 0.0059 |
| 2 | DORAVIRINE | 1 | 0.0013 |
| 3 | FOSCARBIDOPA/FOSLEVODOPA | 11 | 0.0012 |
| 4 | CONJUGATED ESTROGENS/BAZEDOXIFENE | 1 | 0.0011 |
| 5 | BESIFLOXACIN | 1 | 0.0010 |
| 6 | RALTEGRAVIR | 5 | 0.0010 |
| 7 | CLEAR MINT, GEL TOOTHPASTE | 1 | 0.0009 |
| 8 | SODIUM FLUORIDE F18 | 1 | 0.0009 |
| 9 | SODIUM FLUORIDE F-18 | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Janus Kinase Inhibitor [EPC] | 71 |
| 1 | Kinase Inhibitor [EPC] | 49 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 48 |
| 3 | Benzodiazepine [EPC] | 28 |
| 4 | Corticosteroid [EPC] | 28 |
| 5 | BCL-2 Inhibitor [EPC] | 26 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 25 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 25 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 24 |
| 9 | Antirheumatic Agent [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 2 | Catechol-O-Methyltransferase Inhibitor [EPC] | 3 | 0.0006 |
| 3 | Progesterone [EPC] | 14 | 0.0006 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 6 | Janus Kinase Inhibitor [EPC] | 71 | 0.0004 |
| 7 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 8 | BCL-2 Inhibitor [EPC] | 26 | 0.0004 |
| 9 | Nonergot Dopamine Agonist [EPC] | 6 | 0.0004 |